Navigation path

Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: ECOPORC SHIGA   
Auth. number : EU/2/13/149
Active substance : Genetically modified recombinant Stx2e antigen
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI09 - Immunologicals for suidae
Pharmacological subgroup: QI09A - Pig
Chemical subgroup: QI09AB - Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)
Chemical substance: QI09AB02 - escherichia
(See WHO ATCvet Index)
Indication: Active immunisation of piglets from the age of 4 days, to reduce the mortality and clinical signs of oedema disease caused by Stx2e toxin produced by E. coli (STEC).
Onset of immunity: 21 days after vaccination 
Duration of immunity: 105 days after vaccination
Marketing Authorisation Holder: IDT Biologika GmbH
Am Pharmapark, 06861 Dessau-Rosslau, Deutschland
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/04/2013 Centralised - Authorisation EMEA/V/C/2588 (2013)2135 of 10/04/2013
07/03/2014 Centralised - Variation EMEA/V/C/2588/IB/1
Updated with Decision(2015)1428 of 26/02/2015
02/03/2015 Centralised - Yearly update (2015)1428 of 26/02/2015
01/04/2015 Centralised - Variation EMEA/V/C/2588/IB/3
Updated with Decision(2016)2434 of 18/04/2016
20/04/2016 Centralised - Yearly update (2016)2434 of 18/04/2016
22/03/2018 Centralised - Renewal EMEA/V/C/2588/R/6 (2018)1847 of 20/03/2018